Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Jyseleca
Pharma
Galapagos sells its Jyseleca business to Italy's Alfasigma
Galapagos has agreed to sell its Jyseleca business to Alfasigma. Around 400 Galapagos employees will join the Italian company under the deal.
Kevin Dunleavy
Oct 31, 2023 9:10am
Galapagos slashes Jyseleca sales projection, scraps submissions
Aug 4, 2023 11:12am
EMA cracks down on JAK drugs with new limitations
Oct 28, 2022 10:20am
Doctors like AbbVie's Rinvoq in IBD, but not Bristol's Zeposia
Feb 22, 2021 11:17am
